Cancer-specific binary expression system activated in mice by bacteriophage HK022 Integrase

Area of Science:

• Molecular Biology
• Gene Therapy
• Oncology

Background:

• Site-specific recombination systems are utilized for tumor-specific gene expression targeting in preclinical cancer models.
• Existing systems often rely on viral vectors and can exhibit cytotoxicity, limiting their therapeutic potential.

Purpose of the Study:

• To develop and validate a novel cancer-specific binary gene expression system.
• To utilize the Integrase (Int) of the lambdoid phage HK022 for targeted gene activation.

Main Methods:

• Construction of a binary expression system regulated by a tumor-specific promoter and activated by HK022 Integrase (Int).
• Validation of the system's specificity through reporter gene (luciferase) expression in human embryonic kidney 293T (HEK293T) cells.
• Assessment of the system's efficacy in a lung cancer mouse model.

Main Results:

• Demonstrated specific expression of the luciferase reporter gene in HEK293T cells, confirming system functionality.
• Successfully validated the cancer-specific expression in a preclinical lung cancer mouse model.
• The developed system avoids viral vectors and exhibits no inherent cytotoxicity.

Conclusions:

• The HK022 Integrase (Int)-based binary system provides a novel and effective platform for cancer-specific gene expression.
• The absence of viral vectors and cytotoxicity presents significant advantages over existing systems.
• This system holds promise for development into a safer and more targeted cancer cell-killing therapeutic strategy.